logo
Is PepsiCo A Better Stock Than Coca-Cola?

Is PepsiCo A Better Stock Than Coca-Cola?

Forbes8 hours ago
EDMONTON, CANADA - FEBRUARY 15: A Coca-Cola advertisement board with the slogan 'Enjoy! Coca-Cola' ... More stands outside a restaurant in Edmonton, Alberta, Canada, on February 15, 2025. (Photo by Artur Widak/NurPhoto via Getty Images)
PepsiCo's stock (NASDAQ:PEP) has significantly lagged this year, recording a 10% decrease, while its competitor, Coca-Cola stock (NYSE:KO), has experienced a 16% rise. This contrast is mainly attributed to the sluggish North American operations for PepsiCo. The company has encountered a decline in consumer interest for its Frito-Lay snack sector and has dealt with a substantial recall in its Quaker Foods North America branch (oatmeal). These challenges have adversely affected organic sales, prompting PepsiCo to lower its full-year forecast. They now expect core constant-currency EPS to remain flat year-over-year, a notable drop from the earlier anticipated mid-single-digit increase, and foresee only low single-digit growth in organic revenue. This cautious outlook has understandably shaken investor confidence.
In spite of these recent difficulties, our analysis indicates that PepsiCo offers a more attractive investment opportunity than Coca-Cola over the coming years. This belief is rooted in a thorough assessment of historical revenue trends, investment returns, and comparative valuation metrics. The subsequent sections will elaborate on the rationale behind this viewpoint. That said, if you're seeking a potential upside with a more stable experience than an individual stock, consider the High Quality portfolio, which has outperformed the S&P, delivering >91% returns since its launch. Separately, see – SOFI Stock To $30?
How Are Coca-Cola and PepsiCo's Sales Trending?
Coca-Cola has achieved a 7% average annual revenue growth from 2021 to 2024, rising from $38.7 billion to $47.1 billion. This slightly exceeds PepsiCo's 5% average annual growth, which saw its revenue increase from $79.5 billion to $91.9 billion during the same timeframe.
Coca-Cola's revenue growth is driven by strong performance in both its at-home and away-from-home channels. This growth is largely fueled by effective pricing strategies that have enabled the company to handle inflationary pressures. Regionally, North America and Latin America have been the main contributors to this growth, reflecting a strong demand for Coca-Cola's diverse beverage range.
PepsiCo's revenue growth from 2021 to 2024 was propelled by strategic pricing moves and robust performance in its beverage and snack sectors, although growth encountered significant challenges due to operational difficulties. The company benefitted from heightened interest in zero-sugar varieties of Pepsi, and it retained market share advancements in Gatorade. However, PepsiCo's growth path was heavily impacted by the Quaker Oats recall issue, which commenced in late 2023 due to salmonella contamination. The recall was triggered by salmonella that persisted at a PepsiCo facility for up to four years, ultimately resulting in the permanent closure of the Illinois Quaker Oats factory. Despite these obstacles, PepsiCo achieved annual revenue growth, showcasing the strength of its core beverage and Frito-Lay divisions in counterbalancing the notable decline in the Quaker sector.
What About Profitability?
From 2021 to 2024, Coca-Cola experienced a slight decline in its net margin, decreasing from 25.3% to 22.6%. This is associated with rising mixed costs, product mix, and increased marketing expenses. See – Coca-Cola's Net Margin Comparison – for further details.
On the other hand, PepsiCo's net margin increased from 9.6% to 10.4%. While the increase was modest, PepsiCo benefitted from productivity initiatives and effective pricing for its products.
Financial Risk Analysis
In assessing financial risk, Coca-Cola performs slightly better than PepsiCo. Coca-Cola's debt-to-equity ratio of 16% is more advantageous than PepsiCo's 27%. Moreover, its cash-to-assets ratio of 14% surpasses PepsiCo's 8%. In essence, Coca-Cola showcases a stronger debt profile while maintaining a more stable cash position.
KO and PEP: Comparing 4-Year Stock Returns Against the S&P 500
Since early January 2021, Coca-Cola's stock has experienced solid growth, rising approximately 40% from around $50 to its current price of about $70. In contrast, PepsiCo's stock has shown minimal movement, creeping up only about 4% from $130 to $135 during the same timeframe. This underperformance by both beverage giants is particularly noticeable when juxtaposed with the S&P 500, which has surged by roughly 65% since the beginning of 2021.
However, a detailed examination of the annual returns paints a more intricate picture of volatility for both KO and PEP:
When compared to the S&P 500's performance (27% in 2021, -19% in 2022, 24% in 2023, and 23% in 2024), it's evident that both Coca-Cola and PepsiCo underperformed relative to the broader market in 2021, 2023, and 2024. While KO has shown more consistent positive returns throughout the entire period, PEP's recent challenges have affected its overall long-term performance.
PEP Stock: The Superior Beverage Investment Choice?
We contend that PepsiCo (PEP) currently provides a more appealing investment opportunity than Coca-Cola (KO), largely due to its advantageous valuation.
PEP stock trades at merely 17 times its trailing adjusted earnings of $8.03 per share. This is significantly lower than its four-year average price-to-earnings (P/E) ratio of 22 times, indicating it is undervalued relative to its historical performance.
Conversely, KO stock is trading at 25 times its trailing adjusted earnings of $2.89 per share. This valuation is above its own four-year average P/E of 22 times.
Although PepsiCo has faced recent challenges, particularly due to the Quaker issue affecting North American sales, we expect a recovery in this area in the upcoming quarters. Although PepsiCo's revenues are anticipated to remain flat this year, we predict they will return to mid-single-digit growth starting next year. This expected rebound, alongside its current discounted valuation, positions PepsiCo favorably compared to the two beverage giants.
For investors aiming to reduce the inherent volatility linked to individual stocks like KO and PEP, alternate investment strategies are accessible. The Trefis RV strategy, celebrated for its track record of outperforming its all-cap stock benchmark, provides a diversified route to potentially secure robust returns. Likewise, the High Quality portfolio has shown superior performance compared to the S&P 500, yielding returns in excess of 91% since its inception, thus providing potential upside with reduced stock-specific risk.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Intel (NasdaqGS:INTC) Unveils AI-Enhanced ePaper Touchpad for Innovative Laptop Experience
Intel (NasdaqGS:INTC) Unveils AI-Enhanced ePaper Touchpad for Innovative Laptop Experience

Yahoo

time14 minutes ago

  • Yahoo

Intel (NasdaqGS:INTC) Unveils AI-Enhanced ePaper Touchpad for Innovative Laptop Experience

Intel saw a 17% upward price movement over the last month, a striking performance that stands out amidst tech sector advancements. This gain aligns with significant developments, like the launch of a groundbreaking ePaper touchpad solution by E Ink Holdings in collaboration with Intel technologies. Additionally, strategic partnerships and leadership changes at Intel, coupled with broader tech sector optimism seen in Nasdaq gains, likely added to the positive sentiment. Market dynamics suggest that Intel's recent moves align well with investor focus on tech innovation and strategic repositioning, which could lend further confidence to the company's future endeavors. Buy, Hold or Sell Intel? View our complete analysis and fair value estimate and you decide. Uncover the next big thing with financially sound penny stocks that balance risk and reward. The recent collaboration between E Ink Holdings and Intel, combined with strategic partnerships and changes in leadership, holds the potential to impact Intel's ongoing transformation efforts positively. As Intel grapples with organizational complexity and seeks to enhance its innovation play in AI and foundry businesses, these developments could prove crucial in offsetting complexity risks and boosting investor confidence. Despite a 17% rise in its share price over the past month, Intel's longer-term performance remains concerning, with a total return, including dividends, of 25.99% decline over the last year. This performance, when compared to the broader industry, highlights the ongoing challenges Intel faces in achieving growth amid tech sector advancements. Revenue and earnings forecasts could reflect optimism from recent strategic moves. However, broader market dynamics underline critical risks, such as reliance on older manufacturing nodes and geopolitical uncertainties. Analysts currently predict revenue growth of 2.5% annually, which is slower than the overall US market's 8.7% per year growth. Intel's focus on AI and structural transformation could influence future earnings, presenting a pathway for improvement, though benefits may take time to materialize. As the current share price of US$19.94 remains below the average analyst price target of US$21.29, this suggests Intel might still be perceived as undervalued relative to its fair value potential, presenting a mixed outlook for investors as they assess the company's transitional journey. Evaluate Intel's historical performance by accessing our past performance report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGS:INTC. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati

UPS Offers Buyouts to Drivers, a First in Its 117-Year History
UPS Offers Buyouts to Drivers, a First in Its 117-Year History

Wall Street Journal

time17 minutes ago

  • Wall Street Journal

UPS Offers Buyouts to Drivers, a First in Its 117-Year History

United Parcel Service is offering buyouts to delivery drivers for the first time in its 117-year history. The company is seeking cost savings because of stagnant parcel volumes, rising labor costs and a long slump in the company's stock price. UPS UPS -1.34%decrease; red down pointing triangle employs around 330,000 full- and part-time delivery drivers, clerks and package handlers represented by the International Brotherhood of Teamsters. Full-time drivers are eligible for a buyout, the company said. UPS and the union declined to say how many full-time drivers UPS employs.

Moderna (NasdaqGS:MRNA) Joins Russell Midcap Indices In Late June 2025
Moderna (NasdaqGS:MRNA) Joins Russell Midcap Indices In Late June 2025

Yahoo

time23 minutes ago

  • Yahoo

Moderna (NasdaqGS:MRNA) Joins Russell Midcap Indices In Late June 2025

In late June 2025, Moderna underwent significant index changes, adding to the Russell Midcap indices while exiting the Russell Top 200 indices. This reclassification might have signaled a shift in investor perception, aligning with the company's 18% share price increase over the last quarter. Despite the broader market experiencing a rally with indexes like the S&P 500 and Nasdaq reaching record highs, Moderna's earnings report, strategic alliances, and product-related updates added weight to its price movement. These developments occurred against a backdrop of economic optimism, with strong job growth boosting market sentiment. Buy, Hold or Sell Moderna? View our complete analysis and fair value estimate and you decide. Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. The recent index reclassification of Moderna into the Russell Midcap indices and removal from the Russell Top 200 indicates a shift in investor perception, possibly affecting long-term investor strategies. Despite a recent 18% share price increase over the past quarter coinciding with broader market highs, Moderna's five-year total return was a 50.83% decline. This underperformance relative to industry peers indicates the challenges Moderna faces, including decreased revenues and high costs impacting profitability. The news and developments around Moderna's strategic alliances and product updates could potentially bolster future revenue through international market expansion and oncology advancements. Analysts expect revenue growth driven by new product approvals, yet the company's earnings are still forecast to remain negative in the near term. Current share price movements reflect some investor optimism, trading below the consensus price target of US$47.59, suggesting room for growth, provided the company meets these expectations. Unlock comprehensive insights into our analysis of Moderna stock in this financial health report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGS:MRNA. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store